The Food and Drug Administration (FDA) recently cleared ivWatch Model 400 from ivWatch, LLC, a monitoring device that will improve patient care by quickly detecting IV infiltration and extravasation.

Self-advocacy is crucial in healthcare, especially for patients with chronic conditions like cancer, to ensure proper care and treatment. Recognizing signs of IV infiltration and extravasation is ...

When it comes to peripheral intravenous (IV) therapy, doctors and nurses have come to accept that things might not go smoothly. Nearly 80% of hospital patients in the U.S. receive an IV — a procedure ...

Hampton Roads-based medical device company ivWatch, LLC racked up several prestigious recognitions and awards this year for its innovative work in enhancing IV safety. The company, headquartered in ...

Intravenous administration of fluids and medication is incredibly common among hospital patients. But the failure rate of IVs is relatively high--estimated at more than 20%. These issues can result in ...

NEWPORT NEWS, Va., April 8, 2024 /PRNewswire/ -- A new study published in the peer-reviewed British Journal of Nursing this month examines several important metrics that describe the performance of ...

We evaluated prospectively the effect of 11 variables on the survival of PVL. PVL were monitored from the time of cannula placement to discontinuation. Sites were inspected hourly for clinical signs ...